Antidepressant may cut COVID-19–related hospitalization, mortality: TOGETHER
October 29, 2021
In the latest study, fluvoxamine-treated patients had a 32% reduction in hospitalizations and emergency visits, compared with those in the placebo group.
Antidepressant may help COVID-19 patients avoid serious illness
February 5, 2021
Racetrack workers who developed COVID-19 and took a 2-week course of fluvoxamine did not have to be hospitalized and felt better after 2 weeks.